Portage Biotech Inc.
Q2 2026 13F Holders
Symbol
ALP
CUSIP
G7185A136
Type
Equity
Class
SHS NEW
Num filers
18
Total reported value, excl. options
$709 k
Compare 2026 Q2 to
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type